WallStreetZenWallStreetZen

NASDAQ: OTLK
Outlook Therapeutics Inc Stock Ownership - Who owns Outlook Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Outlook Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ghiath M. SukhtianDirector2025-01-173,458,571$2.51
$8.68MBuy
Lawrence A. KenyonChief Financial Officer2024-09-265,000$5.69
$28.45kBuy

1 of 1

OTLK insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OTLK insiders and whales buy or sell their stock.

OTLK Shareholders

What type of owners hold Outlook Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ghiath M. Sukhtian247.72%79,313,849$115.01MInsider
Faisal Ghiath Sukhtian174.55%55,884,786$81.03MInsider
Biolexis Pte Ltd79.47%25,443,159$36.89MInsider
Arun Kumar Pillai71.78%22,982,529$33.32MInsider
Pankaj Mohan25.88%8,285,115$12.01MInsider
Syntone Ventures LLC5.33%1,705,438$2.47MInsider
Blackrock Inc3.42%1,093,522$1.59MInstitution
Vanguard Group Inc2.66%852,540$1.24MInstitution
Jeff Evanson2.53%808,459$1.17MInsider
Terry Dagnon2.04%653,058$946.93kInsider

1 of 3

OTLK vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OTLK2.26%97.74%Net Buying
AVTX8.48%91.52%Net SellingNet Selling
APLT81.28%8.04%Net SellingNet Selling
ACET69.68%19.41%Net SellingNet Selling
IPSC42.30%45.63%Net SellingNet Selling
View Top Biotech Stocks

Outlook Therapeutics Stock Ownership FAQ

Who owns Outlook Therapeutics?

Outlook Therapeutics (NASDAQ: OTLK) is owned by 14.20% institutional shareholders, 613.84% Outlook Therapeutics insiders, and 0.00% retail investors. Ghiath M. Sukhtian is the largest individual Outlook Therapeutics shareholder, owning 79.31M shares representing 247.72% of the company. Ghiath M. Sukhtian's Outlook Therapeutics shares are currently valued at $116.59M.

If you're new to stock investing, here's how to buy Outlook Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.